rx 821002 has been researched along with rasagiline in 1 studies
| Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (rasagiline) | Trials (rasagiline) | Recent Studies (post-2010) (rasagiline) |
|---|---|---|---|---|---|
| 317 | 0 | 45 | 535 | 72 | 314 |
| Protein | Taxonomy | rx 821002 (IC50) | rasagiline (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 2.3865 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 1.0029 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.2115 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.088 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.019 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.2217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Fuster, MJ; García-Sevilla, JA | 1 |
1 other study(ies) available for rx 821002 and rasagiline
| Article | Year |
|---|---|
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |